CD47 and acute myeloid leukemia: The immunologic type of resistance of AML LSC is often associated with expression of immune checkpoint molecules, such as PD‐L1, CD47, TIM3, or other checkpoint molecules.75, 76, 77, 78, 79, 80, 81, 82